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Abstract
A large body of research focuses on the relationship between sleep and mental health. Poor
emotional regulation is costly to the individual’s physical and mental health as well as the
wellbeing of the community and economy. To further understand emotional regulation, the
current study examines the potential interaction of sleep patterns and hormones. The goal of the
current study was to isolate the potentially moderating role of hormones, specifically epinephrine
and norepinephrine, as moderators in the relationship of sleep patterns and emotional regulation.
The hypotheses were that (1) there would be a strong positive relationship between sleep patterns
and emotional regulation, (2) there would be a strong positive moderating impact of epinephrine
on the relationship between sleep patterns and emotional quality, and (3) there would be a strong
negative moderating relationship between sleep patterns and emotional regulation. The sample
included 420 participants, ages 24 to 74 years who completed telephone surveys, had a full
biological assessment, and wore actigraphy watches to measure their sleep. Analyses were
examined using a regression analysis and a moderation model using the PROCESS macro within
SPSS. Results revealed a strong positive relationship for all sleep measures except for sleep time
in partial support of the first hypothesis. Of the 16 moderation models ran, six were significant.
Epinephrine had inconsistent results as a moderator in the relationship between sleep and
emotional regulation. Norepinephrine also had inconsistent results in the relationship between
sleep and emotional regulation. Hypothesis 2 and 3 were partially supported by the data. Clinical
implications of this study are potential hormone-based therapies. Hormone levels may be an
indicator of an emotional dysregulation in an individual. Practical implications of this study may
be using sleep patterns and epinephrine/norepinephrine levels to assess the potential emotional
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dysregulation habits of that individual. Further studies should investigate alternative
relationships of hormones in relation to sleep patterns and emotional regulation.

Keywords: sleep, depression, epinephrine, norepinephrine, mood regulation, depression
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Sleep, Hormones and Emotional Regulation
Sleep deprivation and disruptions are a concerning public health problem (NIH, 2016).
Poor sleep patterns impair our ability to function cognitively, physically and emotionally
(Holdaway, Luebbe & Becker, 2018; Lang & Bradley, 2009; Walker, 2017). This worldwide
lack of quality sleep has been researched more extensively in the past couple of decades due to
its growing consequences. With sleep deprivation well over 50% in the US, drowsy driving is the
cause of more traffic accidents than alcohol and drug related accidents combined (CDC, 2018;
Walker, 2017). In adolescents, 24 consecutive hours of sleep loss results in a reaction time that
is three times longer in comparison to when well rested (Czeisler, 2009). Specifically, cognitive
abilities such as attention, cognitive performance, and quick reaction times are dramatically
impaired when sleep is restricted to seven or fewer hours per night for a week or longer. This
sleep debt leads to the accumulation of adenosine, a hormone that gradually increases the need to
sleep (Walker, 2017). If enough adenosine accumulates, a person’s ability to remain awake is
nearly impossible (Walker, 2017). The amount of sleep time helps to determine how rested a
person is, but is not the only factor.
Even with adequate sleep quantity, growing levels of sleep disorders are disruptive to
sleep (Czeisler, 2009; NHBLI, 2003). Chronic insomnia, the inability to fall asleep or stay
asleep, was observed in at least 10% of the United States population in the mid-nineties (NIH,
2018). This percentage continues to grow, revealing an estimated 50-70 million Americans’
health and daily functions which are hampered by chronic sleep disorders (NIH, 2018). Today,
there are more than 100 different diagnosable sleep disorders (Walker, 2017). Those disorders
are determined by assessing both a person’s sleep quality and quantity.
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The primary focus of the following literature review is the relationship of sleep, both
quantity and quality on emotional and mood regulation. An additional focus of the literature
review is the role of hormones, specifically epinephrine and norepinephrine, in the linkages
between sleep patterns and emotion regulatory capacities. The goal of the current study was to
examine existing data on the relationship between sleep quality and quantity, depression and
anxious arousal, and epinephrine and norepinephrine. The existing literature suggested that there
may be a moderating role of epinephrine and norepinephrine on the interplay of sleep quantity
and quality on emotional regulation.
Significance
As previously determined as an international issue, sleep deprivation and poor sleep
patterns are negatively impacting economic, emotional and personal health. Moreover, the
mental health crisis is also a major concern to a nation’s well being. As countries are working to
resolve both of these, a practical solution may be within each individual’s genetic code. If this
study supports a moderating relationship on the impact of sleep and emotional regulation,
hormone-based intervention may reduce the suffering of millions. This study is relevant because
its findings hold the potential to edify our current mental health prevention and treatment
patterns.
Purpose
The goal of this project was to further qualify the relationship between sleep and
emotional regulation with a specific emphasis on the body’s physiological status. Because the
impact of epinephrine and norepinephrine has not been frequently analyzed on the relationship
between sleep and emotional regulation, this study’s purpose was to provide additional insight
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for further analysis of epinephrine and norepinephrine on the relationship between sleep quantity
and emotional regulation.
Literature Review
The anticipated relationship, based on the literature present, was that the impact of sleep
on emotional regulation would be moderated by epinephrine and norepinephrine. For this reason,
the literature review will begin by assessing sleep patterns, emotional regulation and their
relationship. After this, the role of epinephrine and norepinephrine on the body will introduced.
The interactions of those hormones on both sleep and emotional wellbeing will then be
integrated. Lastly, the current gaps in the literature are addressed and the section will be
concluded with the hypotheses.
Indicators of Sleep Patterns
Sleep patterns are categorized by the nature and amount of sleep. The most widely used
indicators of sleep quality in the current literature are sleep latency (the time it takes one to fall
asleep after laying down), number of awakenings, and sleep efficiency (Ohayon et al., 2017).
Sleep quantity is most commonly assessed as the amount of time spent sleeping. Some studies
use polysomnography to include sleep spent in each of the two main portions of sleep: Rapid Eye
Movement (REM) and Non-Rapid Eye Movement (NREM). REM sleep is an advanced sleep
that occurs usually at the end of the sleep period and is when dreams occur (Ceisler, 2009; Sun et
al., 2013). NREM sleep’s primary functions are memory consolidation and the upkeep of basic
bodily functions (Moreas, Miranda, Loures, Mainieri, & Marmora 2017; Walker, 2017). Because
the body switches between NREM and REM sleep frequently and both offer many similar
benefits, numerous researchers simply use time asleep to indicate sleep quantity. As noted
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earlier, sleep disruptions are associated with negative physical health and behavioral outcomes,
including the capacity to regulate emotions.

Emotional Regulation
Because sleep patterns and emotional wellbeing have such a significant relationship,
emotions and their regulation are also integral to an individual’s wellbeing (Holdaway et al.,
2018; Lang & Bradley, 2009). In the United States, more young adults die by suicide than by any
other cause (Holdaway et al., 2018). Emotional regulation is negatively correlated with suicidal
thoughts and attempts, which argues for the immediacy in understanding how emotional
regulation works. Emotional regulation is the body’s intrinsic and extrinsic ways of assessing
and moderating emotional reactions (Lang & Bradley, 2009; Thompson, 1991). Another way of
defining emotional regulation is endocrine system’s patterns for releasing hormones in response
to what one is feeling and how they need to be feeling to appropriately fit the situation (Sutton,
2004). Indicators of emotional wellbeing have been widely explored and can be assessed by poor
emotional wellbeing through scales such as the Mood And Symptom Questionnaire (MASQ)
(Lang & Bradley, 2009; Watson et al., 1995). An additional indicator of poor emotional
wellbeing is its economic impact. For example, in 2000, it was estimated that 110 million
working days were lost in England due to poor mental health, stacking up to 9 billion pounds
(over 11.88 billion dollars) annually (Walker, 2017). In America, the estimated loss of money
due to depression-related factors was $210.5 billion, a 21% increase in five years (Greenberg et
al., 2015). This financial loss is evidence of the cost of poor emotional regulation to society.
With all of these factors indicating poor emotional regulation, it is important to also clearly
understand emotions themselves.
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A popular belief about emotions is that emotions are the brain’s persuasive tool in
gaining the body’s needs (Greenspan et al., 1969; Lang & Bradley, 2009). The exact definition
of an emotion is the “complex reaction pattern that involves experiential, behavioral and
physiological elements.” indicating the interaction of the external situation with the body’s
hormones (physiological; Nugent, 2013, p.233). Reliable evidence suggests that emotions are
linked to the motivation to survive (NIH, 2010). These hormone circuits, the physiological
element, were designed to reward the body of survival-encouraging behavior and punish it in
reaction to risky behavior. Stated simply, the body used emotions to encourage survival and
avoid danger. Additionally, research on genes and mental health has revealed that a gene
involved in serotonin distribution, 5-HTT, moderates the relationship between stressful
environments and mental health (Caspi et al., 2003). Emotional regulation is thus influenced by
both genetic and cognitive reactions to situations. Patterns of rising depression and anxiety rates
are seen in the United States (Nogueira & Paços, 2009).
One prominent pattern of emotional regulation is the tendency towards fear and anger.
Researchers agree that this was evolutionarily vital in primitive years (Holdaway et al., 2018;
Lang & Bradley, 2009; Sutton, 2004). Now, however, this stress reaction is often caused by
social factors (Lang & Bradley, 2009). Numerous experiments have revealed that a person’s fear
(negative) response begins high and gradually dissipates whereas a desire (positive) response
slowly rises (Lang & Bradley, 2009; Sutton, 2004). In people with poor emotional regulation,
rumination often occurs. Rumination is the obsessive and destructive inability to stop thinking
about certain concepts. When this stress response is activated, it is added to the pre-existing
stress level, leading one to feel helpless. Several other patterns such as these create roadblocks
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for healthily processing one’s emotions (Holdaway et al., 2018; Sutton, 2004). The
categorization of these patterns is discussed below.
Emotional regulation disorders are often quantified by the following: general distress,
depression, anxiety, loss of interest, and high positive affect. Depression is characterized by
lowered mood which often results in fatigue and lack of interest in activities previously found
enjoyable. Anxiety is noted as an increase in the release of stress hormones, heart rate and blood
pressure. High positive affect is identified as feelings of intense joy, whereas positive affect
includes fatigue (Buckby et al., 2008). Each of these elements are in the Mood and Anxiety
Symptom Questionnaire (MASQ), a popular mental health survey (Watson et al., 1995). The
National Institutes of Health (2010) determined the MASQ as a reliable predictor of poor
emotional regulation. Poor sleep habits also play a heavy role in identifying emotional
regulation, although the exact relationship is not completely clear yet.
Sleep and Emotion Regulation
Ample evidence supports that sleep and emotion regulation are closely intertwined
(Ceisler, 2009; Holdaway, 2018; Ohayon et al., 2015; Walker, 2017). Sleep strips away the
emotional tone of a memory so that the content can be remembered (Walker, 2017). When a
stressful situation occurs and an individual is sleep deprived, the emotional sting of the memory
is not reduced. Sleep is responsible for assessing recent memories, tagging them as ‘to be
remembered’ or ‘to be forgotten,’ and placing the selected ones in the hippocampus (main
memory center located in the brain). In a repeated sleep-memory study, a quality afternoon nap
resulted in a 20% increase in memory compared to the group that stayed awake (Walker, 2017).
The electricity of sleep spindles that occur in NREM frees up memory space, increasing the
short-term memory threshold (Walker, 2017). Sleep rightly enhances confidence in memory, a
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trait uncommon in people with poor emotional regulation patterns (Xie et al., 2010). The
inability to remember as a consequence of sleep deprivation is one part of the tie between sleep
and emotional regulation.
The second part of this relationship between sleep and emotional regulation is the brain’s
ability to selectively remember. Several studies in the past decade have unanimously supported
that intention to remember astoundingly impacts memory (Lang & Bradley, 2009). That is, when
the brain tags a memory as being ‘of high importance’, it will add that memory to the
hippocampus for easy access. How does this relate to mental health? When a person has a strong
stress response to a situation, it is an indicator that they need to store the memory. This
frequently leads to rumination (Holdaway et al., 2018; Tsuno, Besset & Ritchie, 2005). This
similarity is likely why psychiatric orders such as depression are the most prevalent of all sleeprelated health conditions (Weich et al., 2010). Numerous studies have gathered large amounts of
data to attempt to detangle the relationship between sleep and emotional regulation. The
following are several examples and their results.
In the past three decades, a large body of research has explored the linkages between
sleep disturbances and mental health issues (Holdaway et al., 2018; Tsuno et al., 2005; Walker,
2017). There is debate as to whether these are independent, comorbid issues, or whether they are
both manifestations of a common underlying pathophysiology. Another contribution to the
muddiness of deciphering the two disorders is the diagnostic element of sleep disturbances in
depression. Sleep deprivation also contributes to inability to focus, increased daytime sleepiness
and frustration, all symptoms of depression. Thus, wakefulness is often spent in guilty thought
patterns and anxiety, increasing mental fatigue and continuing the pattern. A study found that
90% of its participants diagnosed with depression also reported having poor sleep quality (Tsuno
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et al., 2005). A cross-sectional survey of over 750 US adults aged 20-90 revealed a strong
association between number and severity of sleep problems and an increase in depression and
anxiety, respectively (Xie et al., 2010). Given the bidirectional linkages between the two in
reported literature, it is difficult to discern which contribution precedes the other.
The Relationship between Sleep and Emotional Regulation
In an effort to detangle the temporal relationship between emotional regulatory illnesses
such as depression and sleep disturbances, numerous longitudinal studies have been conducted,
most showing strong connections between these factors. Most commonly, a study of 1,271 male
Johns Hopkins students were annually surveyed for indicators of poor sleep and depression.
After 15 years, students who had reported poor sleep quality at the baseline showed a marked
increase in depression compared to their well-resting counterparts. After the 15-year survey, this
trend sharply increased every year (Weish, 2010). Studies such as these have been conducted all
around the world.
A similar study was compiled in Sweden, with 1,870 adults aged 45-65 (Mallon, Broman
& Hetta, 2000). After adjusting for symptoms of depression at baseline, a study conducted by the
Health Maintenance Organization found the predictive period to be 3.5 years. This means that
symptoms of depression were revealed after an average of three and a half years of poor sleep.
Another noteworthy study in Switzerland was structured as an interview based 2-year, 6-wave
follow up study of participants aged 19 and 20. In participants who reported insomnia for at least
2 weeks, depression symptoms emerged for almost every participant (Weich, 2010). Insomnia
was not a precursor to anxiety. Closely related to insomnia is hypersomnia, defined as sleeping
longer than is healthy (Montplaisir, Poirier & DeMontigny, 1990). Ample evidence supports that
those who sleep for longer than ~9.5 hours per evening also have increased risk of depression
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and anxiety (Montplaisir et al., 1990; Lopez, Barateu, Evangelista & Dauvilliers, 2017; Soehner,
Kaplan & Harvey, 2014).
Regardless of the temporal relationship between sleep and poor emotional regulation,
depression is the most prevalent of health conditions related to sleep. With suicide as the second
highest cause of death, understanding the biological indicators is increasingly relevant (NIH,
2016). The biological indicators of poor emotional regulation are seen in hormones such as
epinephrine and norepinephrine.
The Role of Hormones
Epinephrine. Hormone releases are widely understood to directly impact mental health
and thus emotional wellbeing (Nishihara & Mori, 1988; Thompson, 1991). Epinephrine, also
called adrenaline, is a hormone released when one is highly stimulated. Examples of this include
fear and anger. It is located in the Adrenal Medulla and brainstem (Callaham, Madsen, Barton,
Saunders & Pointer, 1992). Epinephrine increases blood pressure and heart rate. It is released
directly into the bloodstream and can be measured in blood, urine and saliva. Artificial
administration is used to stimulate the heart during allergic reactions (Callaham et al., 2003).
Extensive evidence suggests that epinephrine is crucial in the regulation of memory formation by
emotions and arousal (Korol, 2008). Epinephrine has a significant correlation with anxiety and
many other emotional regulation disorders (Callaham et al., 1992). Normally functioning
epinephrine levels gradually increase as one wakes up and significantly decreases as one
prepares for bed. Thus, it is related to sleep patterns and is disrupted when sleep is disrupted
(Walker, 2017). Further disruptions occur when epinephrine levels are abnormal.
Overproduction of epinephrine has been consistently linked to tenseness, palpitation, and
heightened aggression (Callaham et al., 1992). Increased epinephrine levels during sleep have

SLEEP, HORMONES, AND MOOD REGULATION

10

been shown to result in a higher frequency of waking up in the middle of the night and sleep
disturbances (Nishihara & Mori, 1986). A surplus of epinephrine is also observed in adults with
Alzheimer's, a disease that is believed to be closely linked to sleep wellness (Peskind et al.,
1999). However, another hormone similar to epinephrine is norepinephrine. This hormone plays
a less understood role with sleep and emotional regulation.
Norepinephrine. Epinephrine’s complement hormone, norepinephrine is involved in the
emotional links to memory and perception. During sleep, it is responsible for preserving
temporal order of emotional events. Increased norepinephrine is associated with attention and is
located in the same region of the brain that controls long-term memory (Callaham et al., 1992;
Lang & Bradley, 2009). Because of its energy, general activity and fear regulation qualities,
norepinephrine is suggested to be related to emotional regulation (Nutt et al, 2006). As REM
sleep disorders such as sleep paralysis and hallucinations are growing, medical professionals are
diagnosing serotonin and norepinephrine reuptake inhibitors (Lang & Bradley, 2009, Tsuno et
al., 2005; Walker, 2017). There is growing research about the role of norepinephrine in
interpersonal functioning, especially in anxiety and mood disorders (Nogueira & Paços, 2009).
A decreased amount of norepinephrine may lead to emotional dysregulation, as it is a key
player in perception, modulation, and response to pain (Nogueira & Paços, 2009; Silvo, 2009).
Insufficient norepinephrine has been found to be linked to the inability to forget painful events
(Nogueira & Paços, 2009). A handful of studies have observed that upon re-exposure to
traumatic events, PTSD patients have a spiked increase of norepinephrine (Newport & Nemeroff,
2000). Similar studies suggest that increased (injected) norepinephrine is involved in panic
attacks and acute anxiety (Newport & Nemeroff, 2000). This directly contradicts other research
that argues norepinephrine's role in reducing depression and emotional regulation (Honzak,
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1986; Nutt et al., 2006). One study revealed that alcohol abuse has been observed in African
Americans with elevated norepinephrine levels more than in Caucasian men (Ransome, Slopen
Karisson & Williams, 2017). A reduced amount of norepinephrine levels was observed in
alcohol abusers for Caucasian men. This study implies that norepinephrine may have a larger
impact on the African American population than the caucasian population. This study has not
been replicated many times and thus may not be conclusive. There is strong evidence in
numerous studies, including the aforementioned one, that norepinephrine is related to emotional
regulation and may indicate overall wellbeing.
Current Study and Gaps in the Literature
There is a need for research on the effects of epinephrine and norepinephrine on stress
reducing activities. One study found a reduction in the spread of HIV, cancer, depression and
sleep disorders as the direct result of epinephrine and norepinephrine (Moraes et al., 2017). This
study suggests hormones may serve as a potential moderator impacting all aspects of mental and
physical well-being. Although there was a significant relationship between mental wellbeing and
physical health as moderated by norepinephrine and epinephrine, ample replications of this have
yet to be conducted (Moraes et al., 2017). Although sleep is not the only indicator of physical
well-being, a handful of studies have shown a significant reduction in suicide ideation replicated.
Research on norepinephrine in relation to cardiovascular effects on emotional regulation is
conflicting. Research on the impact of norepinephrine on emotional regulation over an extended
period of time is also scarce. Emotional regulation is observed as having a close relationship with
sleep (Walker, 2017). The literature shows that hormones such as epinephrine and
norepinephrine predict sleep patterns. The goal of this study is to analyze the interplay of
emotional regulation, hormones, and sleep patterns. The hypothesis is that there will be a
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moderating role of hormones on the relationship between sleep patterns and emotional
regulation.
Current Research
The primary purpose of this research was to examine the relationship of sleep patterns
(quality, quantity) and mood regulation (general distress, depression, anxiety, loss of interest,
positive affect) as moderated by hormones (i.e., epinephrine and norepinephrine). Specifically,
the current study focused on the effects of sleep patterns on mood disorders in people with
regular hormonal levels versus those with elevated and decreased hormone levels. The goal of
this research was to understand the potential factors, both biological and social, that contribute to
disrupted mood regulation. The findings of the study would have implications for the general
population to better understand the effects of their poor sleep patterns, and to encourage a
governmentally involved solution to the national sleep deprivation issue.
Hypotheses
H1: It was expected that there will be a positive association between sleep patterns (i.e., overall sleep
quality and sleep quantity) and emotional regulation (i.e., general distress, depression, anxiety,
loss of interest, positive affect).
H2: It was expected that there would be a moderating role of epinephrine in the relationship between
sleep patterns (sleep quality and sleep quantity) and emotional regulation (i.e., general distress,
depression, anxiety, loss of interest, positive affect).
H3: It was expected that there would be a moderating role of norepinephrine in the relationship
between sleep patterns (sleep quality and sleep quantity) and emotional regulation (i.e., general
distress, depression, anxiety, loss of interest, positive affect).
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Method
Participants
The sample that the data were obtained from is the second wave of the Midlife in the
United States (MIDUS) longitudinal study (2011). This study consisted of 1054 Americans,
though only a smaller subsample (420) included actigraphy recordings. Actigraphy was recorded
by placing a watch on the participant that measures blood pressure and sleep waves. Only those
with actigraphy data were used for the current study. The participants were derived from three
study pools, all of whom had completed the preceding Likert-type survey (1932). The first pool
(n=794) was the participants who completed the Daily Stress Project at the first time interval.
The Daily Stress Project is a national survey style questionnaire assessing the daily stress of
individuals. The second pool (n=1,048) consisted of sets of twins (for the sake of noting the
impact of genetics) and randomly dialed digits subjects who had participated in the Daily Stress
project at the second time interval and did not participate in the first time interval. Lastly, 180
Milwaukee residents comprised the third group who had completed the baseline MIDUS study
that began in 2005. The 420 participants used for the current project were between the ages of 25
and 74 (60% female) at baseline and were all living in the United States. Participants were
located through random digit dialed responses and were of varied ethnicities, gender, and
demographic backgrounds. None of the participants were institutionalized.
Procedure
Data were collected from 2004-2009 as the second wave of the MIDUS Biomarker study
(Ryff, Seeman & Weinstein, 2017). This study was longitudinal. It consisted of a telephone
survey for eight nights and a comprehensive biological assessment. The response rate for the
entirety of the study was 39.3%. Those who participated in the first study were invited to
participate in the second (MIDUS 2). The MIDUS 2 consisted of two sub-studies. With support
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from the National Institute on Aging, there was the longitudinal survey sample (n = 1,054) and
the Milwaukee sample (n = 201). The Milwaukee sample included a comprehensive biological
assessment for further psychological analysis. This included urine and blood samples, as well as
actigraphy to measure sleep.
The procedure for data analysis was to run a regression analysis for each sleep and
emotional regulation measure to determine associations. Additionally, moderated regression was
examined using the PROCESS macro within SPSS (model 1). Specifically, moderated
regressions were examined to find moderations of hormones on the links between sleep and
emotional regulation. The R-squared was measured to assess the magnitude of the relationship.
Measures
Sleep quantity. Participants were asked to wear an Actiwatch-64 which began collecting
data at 7:00 am on the Tuesday after the initial visit until the day the participant returns the
watch. Time spent asleep was assessed using motion and heart rate. Weekday and weekend sleep
patterns were recorded. The current study only used weekday data.
Sleep quality. As previously stated, participants wore watches during their sleep. These
watches recorded the sleep onset latency, wake after sleep onset (WASO), total wake time, total
activity counts, average activity counts, wake bouts, wake percentage, and cumulative sleep
efficiency. For this study, sleep quality was analysed using onset latency, WASO and sleep
efficiency. The sleep onset latency is defined as the time between the ‘Start Time’ of a given rest
interval and the following ‘Sleep Start Time,’ measured in minutes. It was used to measure the
number of minutes between an individual’s first attempt to sleep and the beginning of their first
sleep stage. WASO is measured by totaling the number of waking epochs between the beginning
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and end of each sleep interval and multiplying that by the minutes of each epoch. It is used as an
indicator of poor sleep quality, as it is the time an individual is awake during their sleep time.
The overall sleep efficiency is the percentage of scored total sleep time to the minutes of the
sleep intervals minus invalid sleep. Invalid sleep is when a person’s sleep status cannot be
confidently recorded in a specific stage. It is also assessed by dividing the Interval Duration
minus Total Invalid time from the Scored Total Sleep time multiplied by 100. Onset Latency,
WASO, and sleep efficiency were all used to measure sleep quality.
Hormones. Epinephrine and norepinephrine were collected through the urine using
High-Pressure Liquid Chromatography (Jiang & Machacek, 1987). Urine samples were taken
overnight, starting at 7:00 pm and ending at 7:00 am. Samples were recorded at the baseline and
again after 12 hours. This study included only the baseline epinephrine and norepinephrine
levels.
Emotional regulation. Emotional Regulation is measured by the Mood and Symptom
Questionnaire (MASQ). The MASQ has questions that assess general distress/depressive
symptoms and anxious arousal symptoms. An example of the anxious arousal items is “(how
much have you felt or experienced things this way during the past week, including today) had
trouble swallowing.” All items were assessed on a 1-5 scale. The mean of the depressive and
anxious arousal scales was used as emotional regulation indicators for this study.
Results
All models were analyzed using SPSS version 23 and the PROCESS macro version 3.
For all models, actigraphy-reported sleep were the predictors, anxiety and depression were the
outcomes, and norepinephrine and epinephrine were the moderators. Of the 16 regression models
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analysed, six showed a significant moderating role of hormones in the relationship between sleep
and emotional regulation. Descriptive statistics and bivariate correlation was examined among all
study measures.
The regression analysis for all emotional regulation and sleep patterns are found inTable
1. In partial support of hypothesis 1, all measurements of emotional regulation were significantly
associated with the measures of sleep quality and quantity except for sleep time (p < .05). The
association between sleep time and and depression was negative but not significant (𝛽 = -.05, R
squared = .002). Similarly, the association between onset latency and sleep time was negative
and not significant (𝛽 = -.01 , R squared = 0). Sleep time was not a reliable indicator or result of
emotional regulation. Onset latency was significantly positively associated to both depression (𝛽
= .11, R squared = .01, p < .05 ) and anxious arousal (𝛽 = .07, R squared = .15, p < .01). Sleep
efficiency was negatively associated with depression (𝛽 = -.14, R squared = .02, p < .01 ) but
positively associated with anxious arousal (𝛽 = .2, R squared = .04, p < .001 ). According to
these results, the longer it took a person to fall asleep, the lower were their depression was and
the higher was their anxious arousal symptoms. The WASO was positively associated with both
depression (𝛽 = .12, R squared = .01, p < .05 ) and anxious arousal (𝛽 = .21, R squared = .04, p
< .001). The more frequently an individual awoke during the sleep time was associated with
higher levels of both depression and anxious arousal. Overall, anxious arousal had more
significant correlations than depression did with sleep measurements such as wake-sleep onset,
onset latency and sleep efficiency (p < .01).
As noted in table 2, there was a statistically significant interaction between sleep time and
norepinephrine in the prediction of depression (B = -.002, p < .05, ULCI = .003, LLCI = .0005).
The total model R-squared was .021, (p < .05) and the interaction R-squared was .018
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(p < .05). As seen in figure 1, findings indicated a moderation of norepinephrine in the relation
between sleep time and depression. At the 10th and 25th percentiles i.e., at lower levels of
epinephrine, higher sleep time was associated with higher levels of depression. There was no
association at moderate and high levels of norepinephrine. At low levels of epinephrine, the more
minutes an individual sleeps, the more depression they may experience. This supported
hypothesis two, that norepinephrine would play a moderating role in the sleep quality and
depression, though not in the anticipated direction.
As indicated on table 2, there was a statistically significant interaction between sleep time
and epinephrine in the prediction of depression (B = .01, p<.05, ULCI = .02, LLCI = 0.001). The
total model R-squared was .02, (p < .05) and the interaction R-squared was .01 (p<.05) (see
Table 2). Findings did not indicate a moderating role of epinephrine at the 10th, 25th, 50th, 75th,
or 90th percentile. The Johnson-Neyman technique revealed that the moderating role of
epinephrine was only significant at the 98.6th percentile level of epinephrine (B = 3.19, p<.05).
Specifically, at extremely high levels of epinephrine, greater sleep time was linked to greater
levels of depressive symptoms (see Table 2). For normal levels, this data did not support
hypothesis two.
There was a statistically significant interaction of the sleep efficiency and epinephrine in
the prediction of anxiety (B = .049, p < .01, ULCI = .086, LLCI = .013) (see Table 2). The total
model R-squared was .04 (p < .001) and interaction R-squared was .009 (p < .01). Findings
indicated a moderation of epinephrine in the relation between sleep efficiency and anxiety, as
seen in figure 3. At low, moderate, and fairly high levels of epinephrine, lower sleep efficiency
was associated with increased anxiety. The only level of epinephrine that did not have an
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association was at the 90th percentile (see Figure 3). For people with low levels of epinephrine,
poor sleep efficiency was associated with increased levels of anxious arousal.
As indicated in table 2, there was a statistically significant interaction between sleep time
and norepinephrine in the prediction of anxiety (B = .001, p < .001, ULCI = .002, LLCI = .0003).
The total model R-squared was .02 (p < .01) and the interaction R-squared was .01 (p < .001).
Findings did not indicate a moderation of norepinephrine at 10th, 25th, 50th, 75th or 90th
percentiles. The Johnson-Neyman Technique revealed that the moderating role was significant at
extremely high and extremely low levels of norepinephrine (see Figure 4). For only extreme
levels of norepinephrine, when an individual has longer sleep time, they will have higher levels
of anxious arousal. At standard levels of norepinephrine, norepinephrine did not change the
relationship between sleep time and anxious arousal.
As indicated in table 2, there was a statistically significant interaction between onset
latency and epinephrine as predictors of depression (B = .03, p<.01, ULCI = -.01, LLCI = -.05).
The total model R-squared was .03 (p < .01) and the interaction R-squared was .02 (p<.01).
Findings indicated a moderation of epinephrine in relation to onset latency and depression at all
levels below the 90th percentile. As seen on figure 5, at high levels of epinephrine, as onset
latency increases, depression also increases. With increased epinephrine, the longer it takes one
to fall asleep, the more depression they have. This is in support of hypothesis one.
As noted on table 2, there was a statistically significant interaction between onset latency
and epinephrine in the prediction of anxiety (B = -.02, p<.05, ULCI = -.009, LLCI = .04). The
total model R-squared was .04 (p < .01) and the interaction R-squared was .02 (p < .01).
Findings indicated a moderating effect of epinephrine in the links of onset latency and anxiety, as
seen in figure 6. At all levels of epinephrine under the 90th percentile, the longer it takes one to
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fall asleep, the higher anxiety they will have. There is no association at extremely high levels of
epinephrine.
Discussion
Hypothesis 1, that emotional regulation measures would be associated with sleep
measures, was supported. All levels of sleep quality were highly associated with depression and
anxious arousal. Neither of the emotional regulation measures were associated with sleep time.
This is supported by previous research that too much sleep can also be maladaptive (Montplaisir
et al., 1990; Lopez et al., 2017; Soehner et al., 2014).
The goal of the study was to explore the moderation of hormones (epinephrine and
norepinephrine) in the sleep to emotion regulation links. The findings support a moderating role
of epinephrine on the relationship between sleep and emotional regulation. When epinephrine
was analyzed as a moderator between sleep onset latency and depression, it was significant for
all levels except for extremely large amounts of epinephrine. In Callaham et al.’s study, (1992),
it was also discovered that large amounts of epinephrine increase anxiety. Other models, such as
sleep time and depression revealed significant amounts for only extreme cases of epinephrine.
This supports Walker’s (2017) meta-analysis of abnormal levels of epinephrine disrupting sleep
time. While the direction in Walker’s meta-analysis was different than the current study, it does
provide evidence of a relationship between sleep time and epinephrine. Further, at normal levels
of epinephrine, only onset latency had a significant negative relationship with depression and
anxiety. The literature provides clarity for this by acknowledging rumination as a maladaptive
thought pattern that is strongest before bed (Holdaway et al., 2018; Sutton, 2004). Thus
rumination may be both why onset latency is increased and is a symptom of poor emotional
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regulation. This supports hypothesis two. The results suggest that epinephrine has a moderating
role of sleep time and onset latency in increasing both depression and anxious arousal, consistent
with Callaham et al.’s (1992) argument that anxiety increases anxiety and stress. The variations
in levels at which it is significant for each variable may be due to a further complexity of the
relationship between epinephrine and sleep time. It may also be due to a confounding variable
such as insomnia. Nonetheless, the data suggest partial support for hypothesis two.
At extremely high levels of epinephrine, sleep time had an increased relationship with
anxiety, but not with depression. While it is not strong enough to be conclusive, the data suggest
that at extremely low amounts of norepinephrine, high levels of sleep time is associated with low
levels of anxious arousal. In contrast, high levels of norepinephrine are associated with high
levels of sleep time and high levels of anxious arousal. This is contrary to both Nogueira &
Paços’ (2009) study and Silvo’s (2009) studies that found heightened acute anxiety was
associated with elevated norepinephrine levels. However, in Newport & Nemeroff’s study
assessing PTSD responses, spikes in stress and anxiety were associated with spikes in
norepinephrine. The only significant model that suggests a moderating role of norepinephrine at
standard levels is on the relationship between sleep efficiency and anxiety. This model reveals
that in individuals with low, moderate, and fairly high levels of norepinephrine, higher sleep
efficiency is related to lower levels of anxious arousal. The literature may support this finding by
observing the relationship between norepinephrine as fear-regulation (Nutt et al., 2006). This
supports the previous literature and hypothesis three, though caution should be exercised with
interpreting extremes of sleep.
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Strengths
This study examined a novel exploration of the role of hormones in the links of sleep and
mental health. The study identified a gap in the current literature and used appropriate
measurements to reduce that gap. The study explored physiological conditions under which sleep
patterns were linked to mental health. The ability to use both objective measures for sleep and
hormone levels and subjective measures for emotional regulation reduces the common method
bias (Jakobsen & Jensen, 2015). Another strength in this study was the use of actigraphy
recorded measures. This allowed for a non-invasive and inexpensive way to gather information
on sleep patterns. Since this is an objective sleep measure, it has a high validity. Multiple
objective measures such as the sleep watch and urine sampling were used for this
study. Additionally, this study had a large sample size and represented a wide range of
demographics in the United States. The sample was diverse and one of the three groups of
participants was randomly sampled, which made conclusions more generalizable and
informative.
Limitations
While using actigraphy is an advanced means of measuring data, a stronger method
would be polysomnography (NIH, 2018). This would reduce the invalid sleep markings and
provide a more thorough understanding of the sleep patterns and sleep stages. Further, using both
urine and blood samples would allow the hormone levels to be confirmed at baseline more so
than only using one. The hormone levels were also only taken once per person as their baseline
levels. If any individuals had circumstances that altered their stress levels and thus epinephrine
or norepinephrine levels, it may have impacted the data. Another limitation to this study was
only having one baseline measurement for epinephrine and norepinephrine levels.
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This study did also not take into account confounding variables that may impact the
relationship between sleep and mental health such as sleep disorders. Especially with
hypersomnia, increased levels of sleep time or decreased levels of sleep efficiency may be
indicators of a different issue which may mediate the relationship between sleep and mental
health (Walker, 2017).
Implications and Future Directions
Practical implications for this study would be to use hormones as an intervention for
sleep disruptions. Clinical implications for this study would be to use hormone-based
interventions for individuals with emotional regulation disorders. Hormones could be used as a
screening for checking the likelihood an individual may develop an emotional regulation
disorder. Further attention should be paid to repeating the study with polysomnography and
multiple measures of epinephrine and norepinephrine. Different hormones should be assessed
and compared as both moderators and mediators in the relationship between sleep and emotional
regulation. Another future direction of this study may be to isolate potentially confounding
factors such as sleep disorders. A practical purpose of further studies can focus on a specific atrisk demographic such as third-shift workers, doctors, and astronauts.
Conclusion
A goal of the current study was to examine the risk enhancing or buffering roles of
hormones epinephrine and norepinephrine in the relationship between sleep quantity/quality and
emotional regulation. The big picture purpose of this direction is to identify a physiological
solution in addition or replacement to the behavioral interventions of poor emotional regulation
in the United States. With both norepinephrine and epinephrine as statistically significant
moderators in the role of sleep patterns and emotional regulation, further research may unlock an
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intervention that resolves emotional dysregulation more than the current interventions. Likewise,
understanding the interactions of sleep and emotional regulation may enhance the quality of life
for every individual. This study began to close the gap in understanding the moderating role of
hormones on links with sleep and emotional regulation and has opened the door for happier,
healthier Americans.
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Table 1
Regression of Sleep, Hormones and Emotional Regulation
Depression
Sleep Time
Onset Latency
Sleep Efficiency
WASO

B(se)

β

-.005(.005) -.047

𝑅2

Anxious Arousal

.002 Sleep Time

B(se)

β

𝑅2

.001(.004)

-.013

0

.07(.01)

.15

.02(.01)*

.11

.01

Onset Latency

-.09(.03)**

-.14

.02

Sleep Efficiency .1(.03)***

.2

.03(.01)*

.12

.01

WASO

.21

.05(.01)***

.02
.04
.04

* is significant at the 0.05 level, ** is significant at the .01 level, *** is significant at
the .001 level.
Note.

Table 2
Model of Epinephrine and Norepinephrine as Moderators in the Relationship between Sleep and
Depression.
Variables
Depression

B(se)

t

LLCI

ULCI

19.114(.375)***

50.9973

18.377

19.85

-.0057(.006)

-9.518

-.0175

.006

Norepinephrine

0.0345(.0375)

.9185

-.04

0.108

Interaction

0.0015(.0005)*

2.8743

.0005

.0025

19.027(.356)

53.443

18.327 19.727

Sleep Time

.004(.006)

-.651

-.016

.008

Epinephrine

.658(.475)

1.385

-.276

1.591

Interaction

.0118(.005)*

2.204

.001

.022

Constant
Sleep Time

Depression

Constant

RSquared
.021*

.018*
.02*

.01*
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18.956(.352)***

53.896

.034(.01)***

3.337

.014

.055

Epinephrine

.39(.448)

.87

-.491

1.27

Interaction

-.0288(.009)**

-3.113

-.047

-.011

Onset Latency

18.264 19.647

.04**

.02**

* is significant at the 0.05 level, ** is significant at the .01 level, *** is significant at
the .001 level.
Note.

Table 3
Model of Epinephrine and Norepinephrine as Moderators in the Relationship between Sleep and
Anxious Arousal.
Variables

Anxiety

B(se)

t

21.973(.277)***

79.335

-.101(.025)

5.26

-4.066

-.052

Epinephrine

.09(.338)

.2676

-.5741

.7549

Interaction

.049(.019)**

2.663

.013

.086

22.121(.287)***

77.066

-.0009(.004)

-.214

-.009

.007

.038(.033)

1.133

-.028

.103

Interaction

.0011(.0004)**

2.599

.002

.01***

Constant

21.977(.278)***

79.195

.0003
21.431

22.52

.037*

Onset Latency

0.3(.01)**

3.147

.011

.049

Epinephrine

.0818(.342)

.239

-.591

.755

Interaction

.0246(.008)**

-3.057

-.041

-.009

Constant
Sleep
Efficiency

Anxiety

Constant
Sleep Time
Norepinephrine

Anxiety

LLCI

ULCI

RSquared

21.429 22.518

.04***

21.557 22.685

* is significant at the 0.05 level, ** is significant at the .01 level, *** is significant at
the .001 level.
Note.

.009***
.02**

.02**
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Figure 1. The moderating effects of Norepinephrine on Sleep Time and Depression.

Figure 2. The moderating effects of Epinephrine on Sleep Time and Depression.
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Figure 3. The Moderating effects of Epinephrine on Sleep Efficiency and Anxious Arousal.

Figure 4. The Moderating effects of Norepinephrine on Sleep Time and Anxious Arousal
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Figure 5. The Moderating Impacts of Epinephrine on Onset Latency and Depression.

Figure 6. The Moderating Impacts of Epinephrine on Onset Latency and Anxious Arousal.
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